These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15808455)

  • 1. Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.
    Guthikonda RN; Shah SK; Pacholok SG; Humes JL; Mumford RA; Grant SK; Chabin RM; Green BG; Tsou N; Ball R; Fletcher DS; Luell S; Euan MacIntyre D; Maccoss M
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1997-2001. PubMed ID: 15808455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative.
    Naka M; Nanbu T; Kobayashi K; Kamanaka Y; Komeno M; Yanase R; Fukutomi T; Fujimura S; Seo HG; Fujiwara N; Ohuchida S; Suzuki K; Kondo K; Taniguchi N
    Biochem Biophys Res Commun; 2000 Apr; 270(2):663-7. PubMed ID: 10753680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorinated dihydroquinolines as potent n-NOS inhibitors.
    Jaroch S; Rehwinkel H; Hölscher P; Sülzle D; Burton G; Hillmann M; McDonald FM; Miklautz H
    Bioorg Med Chem Lett; 2004 Feb; 14(3):743-6. PubMed ID: 14741281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
    Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
    J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
    Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
    J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines.
    Tang W; Li H; Poulos TL; Silverman RB
    Biochemistry; 2015 Apr; 54(15):2530-8. PubMed ID: 25811913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
    J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Identification of 2-azabicyclo[4.1.0]heptan-3-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Odagaki Y; Nakai H; Toda M
    Bioorg Med Chem; 2003 Apr; 11(8):1723-43. PubMed ID: 12659759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
    J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models.
    Bonnefous C; Payne JE; Roppe J; Zhuang H; Chen X; Symons KT; Nguyen PM; Sablad M; Rozenkrants N; Zhang Y; Wang L; Severance D; Walsh JP; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
    J Med Chem; 2009 May; 52(9):3047-62. PubMed ID: 19374401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity.
    Beaton H; Boughton-Smith N; Hamley P; Ghelani A; Nicholls DJ; Tinker AC; Wallace AV
    Bioorg Med Chem Lett; 2001 Apr; 11(8):1027-30. PubMed ID: 11327581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing.
    Guo JS; Cho CH; Wang JY; Koo MW
    Eur J Pharmacol; 2006 May; 536(3):301-8. PubMed ID: 16600210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4,5-dialkylsubstituted 2-imino-1,3-thiazolidine derivatives as potent inducible nitric oxide synthase inhibitors.
    Ueda S; Terauchi H; Yano A; Matsumoto M; Kubo T; Kyoya Y; Suzuki K; Ido M; Kawasaki M
    Bioorg Med Chem; 2004 Aug; 12(15):4101-16. PubMed ID: 15246088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
    Arias F; Franco-Montalban F; Romero M; Carrión MD; Camacho ME
    Bioorg Med Chem; 2021 Aug; 44():116294. PubMed ID: 34218000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms.
    Moore WM; Webber RK; Fok KF; Jerome GM; Connor JR; Manning PT; Wyatt PS; Misko TP; Tjoeng FS; Currie MG
    J Med Chem; 1996 Feb; 39(3):669-72. PubMed ID: 8576908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly selective inhibitor of inducible nitric oxide synthase enhances S-antigen-induced uveitis.
    Charlotte F; Ito S; Wu G; Kimoto T; Rao N
    Curr Eye Res; 2003 Jan; 26(1):1-7. PubMed ID: 12789530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.